IL22 and COVID-19: We investigated the circulating levels of IFNγ, IL-4, sIL-4R, IL-5, IL-9, IL-17A, IL-17F, IL17-E/25, IL-22 and sCD30 in surviving and non-surviving severe COVID-19 patients and healthy controls.